Informação sobre produto
Vorolanib is a small molecule that binds to the death receptor 4 (DR4) and inhibits angiogenesis. Vorolanib is a member of the everolimus group. This drug has been shown to inhibit tumor growth in a mouse model of metastatic cancer by blocking the activation of DR4, which signals cells to grow, and by inhibiting the production of pro-angiogenic factors. Vorolanib has also been shown to have anti-inflammatory properties. Vorolanib binds to the death receptor 4 (DR4) and inhibits angiogenesis by blocking activation of this protein, which signals cells to grow, and by inhibiting the production of pro-angiogenic factors. Vorolanib also has anti-inflammatory properties due to its ability to suppress myeloid derived suppressor cells (MDSCs).
Propriedades químicas
Consulta técnica sobre: 3D-NQB92015 X-82 (Vorolanib)
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.